Richard J. Barohn - Concepedia

Author

Richard J. Barohn

Also Known As

Annabel K. Wang, Anthony A. Amato, Anthony Amato, Barohn, Richard, Barohn, Richard J., Bruce A. Barshop, Ekkehard Wilichowski, Hoda Abdel-Hamid, Jeri Sieren, John T. Kissel

349

Publications

22.2K

Citations

H-Index

156

Concepts

All Affiliations

University of Kansas Medical Center The University of Texas Southwestern Medical Center The University of Texas Health Science Center at San Antonio California Pacific Medical Center University of Kansas

About

Richard J. Barohn is an author at University of Kansas Medical Center specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	48	5.1K
2	Health Sciences	13	14	822
3	Engineering	2	2	428
4	Social Sciences	2	2	155
5	Public Health	1	1	41

Richard J. Barohn

133

Publications

17K

Citations

H-Index

Page 1

	Year	Citations
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai, Annals of the Rheumatic Diseases	2017	1.4K
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai, Arthritis & Rheumatology	2017	678
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial Chester V. Oddis, Ann M. Reed, Rohit Aggarwal, Arthritis & Rheumatism	2012	669
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial Dan H. Moore, Robert G. Miller, Julaine Florence, The Lancet Neurology Neurodegenerative DiseasesAmyotrophic Lateral SclerosisNeurological DisorderPhase IiiNeurology	2007	637
Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis Steven A. Greenberg, Jack L. Pinkus, Geraldine S. Pinkus, Annals of Neurology	2005	602
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Richard J. Barohn Archives of Neurology RheumatologyLumbosacral RadiculopathyVasculitisAutoimmune DiseaseDisease Progression	1989	569
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy Kathryn R. Wagner, James L. Fleckenstein, Anthony A. Amato, Annals of Neurology	2008	457
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Craig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, The Lancet Rare DiseasesUrologyClinical TrialsDegenerative DiseaseRehabilitation	2017	446
Ataluren treatment of patients with nonsense mutation dystrophinopathy K. Bushby, Richard S. Finkel, Brenda Wong, Muscle & Nerve	2014	416
Reliability Testing of the Quantitative Myasthenia Gravis Score<sup>a</sup> Richard J. Barohn, Donald D. McIntire, Laura Herbelin, Annals of the New York Academy of Sciences ReliabilityKinesiologyEngineeringReliability TestingGeneralizability Theory	1998	388

Page 1